Frank Dörje - Concepedia

Author

Frank Dörje

Friedrich-Alexander-Universität Erlangen-Nürnberg ORCID

Also Known As

F Dörje, F. Dorje, F. Dörje, Frank Dorje, Frank Dörje, M. Sponfeldner, Reinhard Bühner

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg Universitätsklinikum Erlangen Comprehensive Cancer Center Erlangen National Institute of Neurological Disorders and Stroke University Hospital Carl Gustav Carus

About

Frank Dörje is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in medicine, pharmacotherapy, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	596
2	Engineering	1	1	378
3	Health Sciences	1	1	21
4	Nursing	1	1	14
5	Public Health	1	1	14

Frank Dörje

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Frank Dörje, J. Wess, G. Lambrecht, Journal of Pharmacology and Experimental Therapeutics	1990	612
In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease Raja Atreya, Helmut Neumann, Clemens Neufert, Nature Medicine InflammationEngineeringAutoimmune DiseaseImmunologyBiomedical Imaging	2014	378
The Influence of Macrolide Antibiotics on the Uptake of Organic Anions and Drugs Mediated by OATP1B1 and OATP1B3 Annick Seithel, Sonja Eberl, Katrin Singer, Drug Metabolism and Disposition	2007	203
Immunological Detection of Muscarinic Receptor Subtype Proteins (m1–m5) in Rabbit Peripheral Tissues Frank Dörje, Allan I. Levey, Mark R. Brann Molecular Pharmacology	1991	168
Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. J. Wess, T I Bonner, Frank Dörje, Molecular Pharmacology	1990	136
Role of P-Glycoprotein Inhibition for Drug Interactions Sonja Eberl, Bertold Renner, Antje Neubert, Clinical Pharmacokinetics BiochemistryP-glycoprotein InhibitionMedicineGlycobiologyPharmacotherapy	2007	113
The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents Pauline Dürr, Katja Schlichtig, Carolin Kelz, Journal of Clinical Oncology	2021	96
Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study Frank Dörje, Judith Schwitulla, Kai‐Uwe Eckardt, Nephrology Dialysis Transplantation	2014	70
Selectivity profile of the novel muscarinic antagonist UH‐AH 37 determined by the use of cloned receptors and isolated tissue preparations Jürgen Wess, G. Lambrecht, E. Mutschler, British Journal of Pharmacology	1991	55
Hospital use of systemic antifungal drugs Katja de With, Michaela Steib–Bauert, Holger Knoth, BMC Clinical Pharmacology	2005	45

Page 1